Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | GLP1R | P43220 | 8/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | CASP2 | P42575 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3691278 | 1.00 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL16247362 | 1.00 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL16247361 | 1.00 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL16244978 | 0.94 | KMT2A (0.55) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL13870513 | 0.92 | KMT2A (0.52) | KMT2ANOD1POLBGLP1RCASP2 | |
| SCHEMBL12848289 | 0.92 | KMT2A (0.52) | KMT2ANOD1POLBGLP1RCASP2 | |
| SCHEMBL19963635 | 0.92 | KMT2A (0.52) | KMT2ANOD1POLBGLP1RCASP2 | |
| SCHEMBL16244963 | 0.92 | DNM1 (0.60) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL16264551 | 0.91 | NOD1 (0.56) | KMT2ANOD1GLP1RLPAR3CASP2 | |
| SCHEMBL9517645 | 0.91 | NOD1 (0.61) | KMT2ANOD1GLP1RLPAR3CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1265638-A1 | COMPOSITIONS FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION OF THERAPEUTIC AGENTS | Pharmaderm Laboratories Ltd. (CA) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001035998-A1 | COMPOSITIONS FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION OF THERAPEUTIC AGENTS | PHARMADERM LABORATORIES, LTD. (CA) | 2001-05-25 | — | — | WO | disclosed |